2017
DOI: 10.1111/tbj.12921
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of HER2 status of breast cancer between Chinese women in China and Chinese-American women in the US

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 6 publications
(6 reference statements)
0
1
0
Order By: Relevance
“…Approximately 1.68 million women are diagnosed with BC worldwide each year and it ranks as the leading cause of cancer-associated cases of mortality in women (1). Although China is a country with a lower incidence of BC, incidence and mortality still ranks the highest for BC in female malignant cancer types (24). BC is a heterogeneous disease that exhibits high sensitivity to chemotherapeutic treatment; approximately 50% of patients with advanced breast cancer benefit from combined chemotherapy, whereas the other half experience only the adverse effects from chemotherapy drugs (5).…”
Section: Introductionmentioning
confidence: 99%
“…Approximately 1.68 million women are diagnosed with BC worldwide each year and it ranks as the leading cause of cancer-associated cases of mortality in women (1). Although China is a country with a lower incidence of BC, incidence and mortality still ranks the highest for BC in female malignant cancer types (24). BC is a heterogeneous disease that exhibits high sensitivity to chemotherapeutic treatment; approximately 50% of patients with advanced breast cancer benefit from combined chemotherapy, whereas the other half experience only the adverse effects from chemotherapy drugs (5).…”
Section: Introductionmentioning
confidence: 99%